A clinical tool for predicting survival in ALS.

Area of Science:

• Neuroscience
• Clinical Neurology

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with variable survival rates.
• Key prognostic factors include onset site, age, diagnosis delay, riluzole, and non-invasive ventilation (NIV).

Purpose of the Study:

• To develop a practical method for individualised ALS prognosis.
• To utilize known prognostic factors for predicting patient survival.

Main Methods:

• Studied 575 consecutive ALS patients from a population-based registry.
• Modeled survival in two steps: diagnosis to respiratory involvement, then respiratory involvement to death.
• Assessed predictor variable effects on each time interval.

Main Results:

• Younger age, longer diagnosis delay, and riluzole use correlated with slower progression to respiratory involvement.
• NIV use was linked to lower mortality post-respiratory involvement.
• Riluzole's effect may be greater in younger patients with longer diagnosis delays.

Conclusions:

• A simple, clinically applicable graphical method for predicting individual ALS survival from diagnosis is presented.
• Further validation in independent cohorts and inclusion of additional factors are recommended.